CA Stock MarketDetailed Quotes

Bright Minds Biosciences Inc (DRUG)

Watchlist
  • 112.630
  • -4.240-3.63%
15min DelayMarket Closed May 12 16:00 ET
1.10BMarket Cap-40.81P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bright Minds Biosciences Inc (DRUG) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2025
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-289.18%-5.82M
-369.77%-8.69M
-538.77%-2.96M
-855.07%-1.81M
-201.24%-2.43M
-81.78%-1.49M
73.66%-1.85M
61.32%-463.17K
114.55%240.16K
46.77%-805.09K
Net income from continuing operations
-15,349.58%-7.57M
-336.46%-12.23M
-428.24%-4.09M
-2,380.51%-5.24M
-413.88%-2.95M
102.95%49.61K
61.99%-2.8M
49.38%-773.44K
115.77%229.9K
72.00%-574.14K
Operating gains losses
188.00%1.43M
-2,987.96%-312.69K
-1,696.30%-1.16M
24,837.69%2.46M
443.28%11.76K
-3,953.47%-1.63M
-122.33%-10.13K
-139.44%-64.46K
107.57%9.88K
-59.39%2.17K
Depreciation and amortization
-8.10%19.79K
4.79%76.87K
-74.62%17.01K
153.02%15.85K
24.12%22.48K
18.88%21.53K
1.25%73.36K
270.03%67.02K
-265.00%-29.89K
-0.01%18.11K
Asset impairment expenditure
----
----
----
----
----
----
--0
----
----
----
Remuneration paid in stock
628.60%1.29M
279.00%3.18M
408.48%1.07M
618.37%1.32M
171.75%615.91K
-19.44%176.39K
-27.11%839.77K
-47.51%210.24K
-22.56%183.94K
656.58%226.64K
Other non cashItems
1.87%6.58K
300.79%35.85K
41,412.52%1.7M
-694,961.16%-1.68M
538.76%13.58K
117.33%6.46K
-54.71%8.95K
8.03%4.09K
-105.29%-242
-60.14%2.13K
Change In working capital
-740.39%-996.37K
1,294.00%554.99K
1,176.05%1.19M
-147.33%-379.48K
71.12%-138.63K
-120.45%-118.56K
104.23%39.81K
136.57%93.39K
52.35%-153.43K
-200.16%-479.99K
-Change in receivables
-81.96%-30.56K
-2,639.92%-362.85K
-325.72%-140.44K
-107.29%-39.07K
67.23%-166.55K
-108.43%-16.8K
-111.15%-13.24K
-149.46%-32.99K
862.32%536.01K
-2,061.29%-508.21K
-Change in prepaid assets
-42.89%-59.05K
-308.22%-771.28K
-76.56%-279.52K
-613.91%-307K
-955.94%-143.44K
-843.64%-41.32K
-238.17%-188.94K
-238.82%-158.31K
-215.89%-43K
181.02%16.76K
-Change in payables and accrued expense
-1,400.22%-906.76K
598.01%1.69M
466.10%1.61M
94.83%-33.41K
1,395.54%171.36K
-110.20%-60.44K
120.21%241.99K
165.28%284.69K
-123.84%-646.44K
-97.58%11.46K
Cash from discontinued investing activities
Operating cash flow
-289.18%-5.82M
-369.77%-8.69M
-173.77%-1.27M
-1,559.00%-3.5M
-201.24%-2.43M
-81.78%-1.49M
73.66%-1.85M
61.32%-463.17K
114.55%240.16K
46.77%-805.09K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-74.27%13.39M
10,456.43%85.57M
141,535.98%33.32M
23.17%-16.87K
1,126.47%225.38K
5,826.92%52.04M
-62.98%810.57K
-8.83%-23.56K
-2.18%-21.96K
-2.17%-21.96K
Net issuance payments of debt
-9.39%-26.03K
-11.61%-100.15K
-9.43%-26.11K
-16.68%-25.62K
-12.17%-24.63K
-8.35%-23.79K
-4.20%-89.73K
-10.23%-23.86K
-2.18%-21.96K
-2.17%-21.96K
Net common stock issuance
-71.33%13.94M
9,021.95%82.1M
--33.47M
--0
--0
5,303.22%48.63M
-26.08%900K
--0
--0
--0
Proceeds from stock option exercised by employees
-99.75%8.75K
1,301,295.70%3.93M
50,231.46%152K
--8.75K
--250.01K
--3.52M
-99.97%302
--302
--0
--0
Net other financing activities
-540.37%-536.12K
---360.14K
---276.42K
--0
--0
---83.72K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-74.27%13.39M
10,456.43%85.57M
141,535.98%33.32M
23.17%-16.87K
1,126.47%225.38K
5,826.92%52.04M
-62.98%810.57K
-8.83%-23.56K
-2.18%-21.96K
-2.17%-21.96K
Net cash flow
Beginning cash position
1,349.43%82.91M
-15.23%5.72M
730.14%51.39M
838.57%55.68M
756.25%57.9M
-15.23%5.72M
-41.97%6.75M
-23.86%6.19M
-38.66%5.93M
-39.69%6.76M
Current changes in cash
-85.01%7.57M
7,494.66%76.88M
6,684.81%32.05M
-1,713.55%-3.52M
-165.99%-2.2M
90,232.60%50.55M
78.50%-1.04M
60.08%-486.73K
113.05%218.2K
46.09%-827.05K
Effect of exchange rate changes
-188.07%-1.44M
2,567.45%312.63K
-3,291.77%-529.04K
-2,048.12%-771.55K
-678.29%-16.85K
3,954.03%1.63M
125.84%11.72K
110.14%16.58K
-69.64%39.61K
59.39%-2.17K
End cash Position
53.80%89.05M
1,349.43%82.91M
1,349.43%82.91M
730.14%51.39M
838.57%55.68M
756.25%57.9M
-15.23%5.72M
-15.23%5.72M
-23.86%6.19M
-38.66%5.93M
Free cash from
-289.18%-5.82M
-369.77%-8.69M
-173.77%-1.27M
-1,559.00%-3.5M
-201.24%-2.43M
-81.78%-1.49M
73.66%-1.85M
61.32%-463.17K
114.55%240.16K
46.77%-805.09K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Dec 31, 2025(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -289.18%-5.82M-369.77%-8.69M-538.77%-2.96M-855.07%-1.81M-201.24%-2.43M-81.78%-1.49M73.66%-1.85M61.32%-463.17K114.55%240.16K46.77%-805.09K
Net income from continuing operations -15,349.58%-7.57M-336.46%-12.23M-428.24%-4.09M-2,380.51%-5.24M-413.88%-2.95M102.95%49.61K61.99%-2.8M49.38%-773.44K115.77%229.9K72.00%-574.14K
Operating gains losses 188.00%1.43M-2,987.96%-312.69K-1,696.30%-1.16M24,837.69%2.46M443.28%11.76K-3,953.47%-1.63M-122.33%-10.13K-139.44%-64.46K107.57%9.88K-59.39%2.17K
Depreciation and amortization -8.10%19.79K4.79%76.87K-74.62%17.01K153.02%15.85K24.12%22.48K18.88%21.53K1.25%73.36K270.03%67.02K-265.00%-29.89K-0.01%18.11K
Asset impairment expenditure --------------------------0------------
Remuneration paid in stock 628.60%1.29M279.00%3.18M408.48%1.07M618.37%1.32M171.75%615.91K-19.44%176.39K-27.11%839.77K-47.51%210.24K-22.56%183.94K656.58%226.64K
Other non cashItems 1.87%6.58K300.79%35.85K41,412.52%1.7M-694,961.16%-1.68M538.76%13.58K117.33%6.46K-54.71%8.95K8.03%4.09K-105.29%-242-60.14%2.13K
Change In working capital -740.39%-996.37K1,294.00%554.99K1,176.05%1.19M-147.33%-379.48K71.12%-138.63K-120.45%-118.56K104.23%39.81K136.57%93.39K52.35%-153.43K-200.16%-479.99K
-Change in receivables -81.96%-30.56K-2,639.92%-362.85K-325.72%-140.44K-107.29%-39.07K67.23%-166.55K-108.43%-16.8K-111.15%-13.24K-149.46%-32.99K862.32%536.01K-2,061.29%-508.21K
-Change in prepaid assets -42.89%-59.05K-308.22%-771.28K-76.56%-279.52K-613.91%-307K-955.94%-143.44K-843.64%-41.32K-238.17%-188.94K-238.82%-158.31K-215.89%-43K181.02%16.76K
-Change in payables and accrued expense -1,400.22%-906.76K598.01%1.69M466.10%1.61M94.83%-33.41K1,395.54%171.36K-110.20%-60.44K120.21%241.99K165.28%284.69K-123.84%-646.44K-97.58%11.46K
Cash from discontinued investing activities
Operating cash flow -289.18%-5.82M-369.77%-8.69M-173.77%-1.27M-1,559.00%-3.5M-201.24%-2.43M-81.78%-1.49M73.66%-1.85M61.32%-463.17K114.55%240.16K46.77%-805.09K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -74.27%13.39M10,456.43%85.57M141,535.98%33.32M23.17%-16.87K1,126.47%225.38K5,826.92%52.04M-62.98%810.57K-8.83%-23.56K-2.18%-21.96K-2.17%-21.96K
Net issuance payments of debt -9.39%-26.03K-11.61%-100.15K-9.43%-26.11K-16.68%-25.62K-12.17%-24.63K-8.35%-23.79K-4.20%-89.73K-10.23%-23.86K-2.18%-21.96K-2.17%-21.96K
Net common stock issuance -71.33%13.94M9,021.95%82.1M--33.47M--0--05,303.22%48.63M-26.08%900K--0--0--0
Proceeds from stock option exercised by employees -99.75%8.75K1,301,295.70%3.93M50,231.46%152K--8.75K--250.01K--3.52M-99.97%302--302--0--0
Net other financing activities -540.37%-536.12K---360.14K---276.42K--0--0---83.72K----------------
Cash from discontinued financing activities
Financing cash flow -74.27%13.39M10,456.43%85.57M141,535.98%33.32M23.17%-16.87K1,126.47%225.38K5,826.92%52.04M-62.98%810.57K-8.83%-23.56K-2.18%-21.96K-2.17%-21.96K
Net cash flow
Beginning cash position 1,349.43%82.91M-15.23%5.72M730.14%51.39M838.57%55.68M756.25%57.9M-15.23%5.72M-41.97%6.75M-23.86%6.19M-38.66%5.93M-39.69%6.76M
Current changes in cash -85.01%7.57M7,494.66%76.88M6,684.81%32.05M-1,713.55%-3.52M-165.99%-2.2M90,232.60%50.55M78.50%-1.04M60.08%-486.73K113.05%218.2K46.09%-827.05K
Effect of exchange rate changes -188.07%-1.44M2,567.45%312.63K-3,291.77%-529.04K-2,048.12%-771.55K-678.29%-16.85K3,954.03%1.63M125.84%11.72K110.14%16.58K-69.64%39.61K59.39%-2.17K
End cash Position 53.80%89.05M1,349.43%82.91M1,349.43%82.91M730.14%51.39M838.57%55.68M756.25%57.9M-15.23%5.72M-15.23%5.72M-23.86%6.19M-38.66%5.93M
Free cash from -289.18%-5.82M-369.77%-8.69M-173.77%-1.27M-1,559.00%-3.5M-201.24%-2.43M-81.78%-1.49M73.66%-1.85M61.32%-463.17K114.55%240.16K46.77%-805.09K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +1.55%
Sample Name
Sample Code
 +1.28%
4
SINOPEC CORP
00386
+0.65%
5
CNOOC
00883
-0.30%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +67.26%
Sample Name
Sample Code
 +44.28%
Sample Name
Sample Code
 +32.47%
4
Loongson Technology Corporation
688047
+31.76%
5
Business-intelligence Of Oriental Nations Corporation
300166
+27.06%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -